Key Trends and Insights into the Acute Lung Injury Market: Growth Rate and Opportunities to 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the acute lung injury market grown in recent years?
In recent times, there has been a consistent expansion in the market size for acute lung injury. The market, which is expected to grow from $2.48 billion in 2024 to $2.60 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 4.7%. The previously observed growth could be attributed to factors such as awareness campaigns, a rise in ICU admissions, the impact of smoking and air pollution, hospital-acquired infections, and efforts to decrease the mortality rate.
How is the acute lung injury market size expected to evolve during the forecast period?
Over the coming years, the market for acute lung injury is expected to experience stable growth. The market size is projected to reach $3.09 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.4%. This predicted growth over the forecast period can be linked to advancements in biologics and gene therapies, government investments and grants, as well as the evolution of precision medicine, regenerative medicine, and stem cell therapies. Additionally, comprehensive health policy changes on a global scale is contributing to this growth. The forecast period will also witness major trends like the creation of biologic drugs, the adoption of wearable and remote monitoring devices, therapies based on inhalation, the use of CRISPR and gene editing technologies, and the implementation of biosensors for real-time analysis.
Get your acute lung injury market report here!
https://www.thebusinessresearchcompany.com/report/acute-lung-injury-global-market-report
Which key drivers are propelling the acute lung injury market’s growth?
The increasing incidence of respiratory disorders is projected to fuel the expansion of the acute lung injury market in the future. Respiratory illnesses encompass a variety of issues affecting the lungs and other components of the respiratory system, resulting in challenges in breathing and hindered lung function. The surging rate of respiratory disorders could be attributed to escalated levels of air pollution, tobacco use, lack of physical activity, the aging demographic, and the influence of viral infections. Respiratory diseases such as pneumonia could trigger acute lung injury by initiating intense inflammation and harming the alveoli, leading to hindered gas exchange and respiratory distress. For example, the Australian Bureau of Statistics reported in September 2023 that the mortality rate due to Influenza and pneumonia had escalated from 31.9 per 100,000 individuals in 2021 to 42.6 per 100,000 individuals in 2022 in Australia, which is a significant increase of around 33.54%. Hence, the escalating incidence of respiratory diseases is catalyzing the growth of the acute lung injury market.
What are the market segments in the acute lung injury industry?
The acute lung injury market covered in this report is segmented –
1) By Injury Type: Direct Injury, Indirect Injury
2) By Therapy: Mechanical Ventilation, Pharmacotherapy, Fluid Management, Other Therapies
3) By End User: Hospitals, Clinics, Other End Users
Subsegments:
1) By Direct Injury: Trauma-Induced Acute Lung Injury, Aspiration Pneumonitis, Pneumonia-Related Acute Lung Injury, Inhalation Injury
2) By Indirect Injury: Sepsis-Related Acute Lung Injury, Shock-Induced Acute Lung Injury, Acute Lung Injury Due To Blood Transfusion, Acute Lung Injury Associated With Pancreatitis
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20704&type=smp
Which leading companies are shaping the growth of the acute lung injury market?
Major companies operating in the acute lung injury market are Thermo Fisher Scientific Inc., GlaxoSmithKline plc, Medtronic plc, Baxter International Inc., Ono Pharmaceutical Co Ltd., Aster DM Healthcare, Octapharma AG, Cartesian Therapeutics Inc., Vapotherm Inc., Stemedica Cell Technologies Inc., Implicit Bioscience Ltd., Apeiron Biologics AG, Faron Pharmaceuticals Ltd., Histocell Sociedad Limitada, Vasomune Therapeutics Inc, Windtree Therapeutics Inc., Qx Therapeutics Inc., Asklepion Pharmaceuticals LLC, ReAlta Life Sciences Inc., MediciNova Inc.
What key trends are currently impacting the acute lung injury market’s development?
Prominent businesses in the acute lung injury market are centering their efforts on creating innovative treatments like peptide therapies to maintain their market dominance. Peptide therapy is a medical treatment employing short amino acid chains, or peptides, in handling various health conditions. For instance, in November 2022, Indian healthcare company Zuventus Healthcare Ltd., launched Aviptadil, a drug specifically designed for acute respiratory distress syndrome (ARDS) treatment. The drug boasts various distinctive advantages such as powerful vasodilatory properties that are 50 times superior to prostacyclin, a lung defense system that boosts surfactant production through binding with alveolar type II cells, anti-inflammatory effects that curtail the activity of pro-inflammatory cytokines such as IL-6 and TNF-alpha, and an immunomodulatory action that supervises immune responses happening in the lungs. Clinical studies have proven Aviptadil’s effectiveness in enhancing the prognosis for severe viral-related ARDS patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20704
Which geographic areas are influencing the growth of the acute lung injury market?
North America was the largest region in the acute lung injury market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute lung injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Lung Cancer Drugs Global Market Report 2025
https://thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report
Lung Cancer Diagnostic And Screening Global Market Report 2025
Small Cell Lung Cancer Therapeutics Global Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
